Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Dharma Master Jiantai Symposium in Targeted Therapy: Systematic Elucidation of Nononcogene Targets

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Chemical biology-based approach to understanding and overcoming resistance of cancers to therapies
Stuart L Schreiber
Harvard University and Broad Institute, Cambridge, MA, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Inactivating STK11/LKB1 genomic alterations are a major driver of primary resistance to PD-1 axis blockade in non-squamous non-small cell lung cancer
Ferdinandos Skoulidis
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Strategies to overcome resistance to targeted therapy of lymphoma based on functional genomic and chemical screens
Louis M Staudt
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Systematic interrogation of cancer dependencies and synthetic lethal interactions
William C Hahn
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4